People · Operator
Named in public records as an officer, director or promoter · active 2009–2014 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| 20/20 GeneSystems, Inc. | — | Biotechnology | Seed | $8.7M | $88.8M | 2014 |
| Envisionier Medical Technologies, Inc. | — | Other Health Care | Pre-Seed | $390K | $12.0M | 2009 |
Michael Hertzberg at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Hertzberg on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Caroline Popper | 1 | 5 |
| Jonathan Cohen | 1 | 5 |
| Kyparissia Sirinakis | 1 | 4 |
| Joel Kanter | 1 | 2 |
| Larry Shulman | 1 | 1 |
| Robert Hoxie | 1 | 1 |
| Patrick Melder | 1 | 1 |
| David Guy | 1 | 1 |
| Dean Hautamaki | 1 | 1 |
| Vladimir Knezevic | 1 | 1 |
| Donald Wallach | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.